2 years ago|discuss
user: mulvya
383 karma | created 9 years ago
recent submissions
2 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
3 years ago|discuss
4 years ago|discuss
4 years ago|discuss
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
(researchsquare.com)
2 pts|4 years ago|discuss
4 years ago|discuss
4 years ago|discuss
4 years ago|discuss
4 years ago|discuss
4 years ago|discuss
4 years ago|discuss
4 years ago|discuss